The Department of Defense’s Neurofibromatosis Research Program (NFRP) offers the New Investigator Award (NIA) to support promising independent investigators in neurofibromatosis (NF) research. This grant aims to facilitate career transition and continued development in the field. Applicants, including those with limited NF experience, must provide preliminary data and are encouraged to collaborate with experienced NF researchers. Priority areas include research on NF complications with high mortality (e.g., neoplasms) or morbidity (e.g., skeletal, learning deficits, pain), refinement of diagnostic and quality of life metrics, and translational research, such as preclinical testing of therapeutic agents. While research involving human subjects is permitted, clinical trials are strictly excluded under this funding opportunity.
Opportunity ID: 52269
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-10-NFRP-NIA |
| Funding Opportunity Title: | DoD Neurofibromatosis New Investigator Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 3 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 02, 2010 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | May 20, 2010 |
| Current Closing Date for Applications: | May 20, 2010 |
| Archive Date: | Jun 19, 2010 |
| Estimated Total Program Funding: | $1,800,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The NFRP New Investigator Award (NIA) mechanism was first offered in FY99. Since that time, 179 NIA applications have been received, and 38 have been recommended for funding. The intent of the NFRP NIA is to support the career transition and/or continued development of promising independent investigators in the field of neurofibromatosis research. Experience in NF research is allowed, but not required. However, Principal Investigators (PIs) with a limited background in NF research are strongly encouraged to have a collaborator who is experienced in the NF field. NIA proposals must include preliminary data originating from the PI, research team, or collaborator that is relevant to NF and the proposed project. Areas of Encouragement: The FY10 NFRP encourages research proposals that specifically address the critical needs of the NF community in the following areas: Complications of NF with high mortality such as neoplasms and cerebrovascular abnormalities; DOD FY10 Neurofibromatosis New Investigator Award 3 Complications of NF with high morbidity such as skeletal maladies, learning deficits, hormone-associated effects, and pain; Refinement and standardization of imaging techniques, molecular and cellular markers, and quality of life metrics for use in future clinical trials; and Translational research such as the development or preclinical testing of therapeutic agents for the treatment of NF. Research involving human subject use is permitted; however, clinical trials are NOT ALLOWED under this funding opportunity. In general, a clinical trial is defined as a prospective study where an intervention (e.g., device, drug, behavioral, surgical procedure, or other) is tested on human subjects for a measurable outcome. PIs wishing to apply for funding for a clinical trial should utilize the FY10 NFRP Clinical Trial Award mechanism. Refer to the General Application Instructions, Appendix 5, for additional information about studies involving human subjects, human subjects data, or human anatomical substances. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org Email:cdmrp.pa@amedd.army.mil |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 52269 Full Announcement-1 -> fy10 cdmrp detailed budget and justification form-1.pdf
Folder 52269 Full Announcement-1 -> fy10 cdmrp biosketch-1.pdf
Folder 52269 Full Announcement-1 -> fy10 nfrp statement of eligibility nia.pdf
Folder 52269 Full Announcement-1 -> nfrp_fy10 nia pa_gg.pdf
Packages
| Agency Contact Information: | PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil eReceipt HELP: 301-682-5507; help@cdmrp.org Email: cdmrp.pa@amedd.army.mil |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00016889 | Mar 02, 2010 | May 20, 2010 | View |
Package 1
Mandatory forms
52269 RR_SF424_1_2-1.2.pdf
52269 PerformanceSite_1_4-1.4.pdf
52269 RR_KeyPersonExpanded_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
